Astellas Pharma | 4503 - Cash And Equivalent


Astellas Pharma reported JPY281.6B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Astellas Pharma JPY 281.6B 93.23B Mar/2026
Chugai Pharma JPY 426.6B 29.83B Dec/2025
Daiichi Sankyo JPY 449.81B 92.35B Mar/2026
Eisai JPY 245.42B 56.22B Mar/2026
Kyowa Hakko Kirin JPY 218.77B 15.83B Dec/2025
M3 JPY 156.18B 22.33B Mar/2026
Otsuka Holdings JPY 534.64B 123.53B Dec/2025
Shionogi JPY 711.4B 477.53B Mar/2026
Sumitomo Dainippon JPY 44.31B 5.82B Mar/2026
Takeda JPY 460.98B 134.07B Jun/2026
Terumo JPY 217.16B 12.86B Sep/2025